Paragonix Technologies, a leader in organ transplant technologies and procurement services, has achieved a significant milestone by successfully completing the first-ever human case using its innovative PancreasPak™ Organ Preservation System.

This landmark procedure was carried out by Dr. Matthew Hunter Witt at the Tampa General Hospital (TGH) Transplant Institute, successfully protecting a donor pancreas throughout its journey to the recipient.

The PancreasPak™ System is the first commercially available hypothermic preservation solution specifically designed for the preservation and transport of donor pancreata.

It actively safeguards the organ for nearly 10 hours, ensuring it remains within the optimal temperature range and thus avoiding the typical risks associated with traditional transport methods.

Unlike standard practices that rely on plastic coolers and crushed ice, which can expose the pancreas to harmful freezing temperatures, this system allows for real-time monitoring of both temperature and location.

This capability provides transplant teams with continuous visibility of the organ's conditions during transport.

The pancreas is particularly fragile and susceptible to damage, making its preservation during transport critical. Given the limited number of pancreas transplants worldwide and the high rate of organ declines, the sector has seen little investment in this area until now.

Paragonix Technologies aims to enhance the preservation of all donor organs, ensuring that healthcare professionals in pancreatic transplants have access to the latest technologies and that patients receive the highest standard of care.




Source: paragonixtechnologies.com

Report Abuse